Brown Victoria L. 4
4 · Apellis Pharmaceuticals, Inc. · Filed Oct 9, 2020
Insider Transaction Report
Form 4
Brown Victoria L.
Program Team Lead
Transactions
- Exercise/Conversion
Common Stock
2020-10-07$18.98/sh+12,000$227,760→ 15,607 total - Sale
Common Stock
2020-10-07$35.00/sh−12,000$420,000→ 3,607 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-10-07−12,000→ 39,268 totalExercise: $18.98Exp: 2029-03-06→ Common Stock (12,000 underlying)
Footnotes (2)
- [F1]This includes 482 shares acquired under the ESPP Purchase on April 30, 2020.
- [F2]This option was granted on March 7, 2019 and will vest as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to continued service.